Anzeige
Meldung des Tages: Der Vorteil des Meeresbodens: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

PAVmed News

Aktie
WKN:  ISIN:  US70387R5028 US-Symbol:  PAVM
9,29 $
+0,18 $
+1,98%
7,8770 € 15:30:00 Uhr
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
-
KGV
-
Index-Zuordnung
-

PAVmed News

10.09.25 - PR Newswire
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock PR Newswire
09.09.25 - PR Newswire
Lucid Diagnostics Announces Proposed Public Offering of Common Stock
Lucid Diagnostics Announces Proposed Public Offering of Common Stock PR Newswire
05.09.25 - PR Newswire
Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025
Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025 PR Newswire
27.08.25 - PR Newswire
Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025
Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025 PR Newswire
26.08.25 - PR Newswire
PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology
PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology PR Newswire
14.08.25 - PR Newswire
PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results
PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results PR Newswire
13.08.25 - PR Newswire
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results PR Newswire
05.08.25 - PR Newswire
Lucid Diagnostics to Participate in Upcoming Investor Conferences
Lucid Diagnostics to Participate in Upcoming Investor Conferences PR Newswire
31.07.25 - PR Newswire
PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025
PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025 PR Newswire
30.07.25 - PR Newswire
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 PR Newswire
16.07.25 - PR Newswire
MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test
MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test PR Newswire
24.06.25 - PR Newswire
PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing
PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing PR Newswire
18.06.25 - PR Newswire
Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test
Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test PR Newswire
03.06.25 - PR Newswire
PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove ...
27.05.25 - PR Newswire
Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes
Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes PR Newswire
15.05.25 - PR Newswire
PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results
PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results PR Newswire
14.05.25 - PR Newswire
Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results
Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results PR Newswire
01.05.25 - PR Newswire
PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025
PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025 PR Newswire
30.04.25 - PR Newswire
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 PR Newswire
24.04.25 - PR Newswire
NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD
NCI-​Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD PR Newswire

Newssuche

Videos

newspaper
16.04.26 +0,31%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »